263 related articles for article (PubMed ID: 31246990)
21. Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2.
Shankar Babu M; Mahanta S; Lakhter AJ; Hato T; Paul S; Naidu SR
PLoS One; 2018; 13(2):e0191419. PubMed ID: 29394289
[TBL] [Abstract][Full Text] [Related]
22. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
[TBL] [Abstract][Full Text] [Related]
23. Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines.
Thonsri U; Seubwai W; Waraasawapati S; Wongkham S; Boonmars T; Cha'on U; Wongkham C
Anticancer Res; 2020 Sep; 40(9):5115-5124. PubMed ID: 32878800
[TBL] [Abstract][Full Text] [Related]
24. Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer.
Chao TK; Huang TS; Liao YP; Huang RL; Su PH; Shen HY; Lai HC; Wang YC
PLoS One; 2017; 12(7):e0182166. PubMed ID: 28753677
[TBL] [Abstract][Full Text] [Related]
25. Cutting off the fuel supply to calcium pumps in pancreatic cancer cells: role of pyruvate kinase-M2 (PKM2).
James AD; Richardson DA; Oh IW; Sritangos P; Attard T; Barrett L; Bruce JIE
Br J Cancer; 2020 Jan; 122(2):266-278. PubMed ID: 31819190
[TBL] [Abstract][Full Text] [Related]
26. [RBMX overexpression inhibits proliferation, migration, invasion and glycolysis of human bladder cancer cells by downregulating PKM2].
Yan Q; Zeng P; Huang S; Tan C; Zhou X; Qiao J; Zhao X; Feng L; Zhu Z; Zhang G; Hu H; Chen C
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):9-16. PubMed ID: 38293971
[TBL] [Abstract][Full Text] [Related]
27. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
[TBL] [Abstract][Full Text] [Related]
28. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
[TBL] [Abstract][Full Text] [Related]
29. SIRT2-Mediated Deacetylation and Tetramerization of Pyruvate Kinase Directs Glycolysis and Tumor Growth.
Park SH; Ozden O; Liu G; Song HY; Zhu Y; Yan Y; Zou X; Kang HJ; Jiang H; Principe DR; Cha YI; Roh M; Vassilopoulos A; Gius D
Cancer Res; 2016 Jul; 76(13):3802-12. PubMed ID: 27197174
[TBL] [Abstract][Full Text] [Related]
30. The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer.
Wang JZ; Zhu W; Han J; Yang X; Zhou R; Lu HC; Yu H; Yuan WB; Li PC; Tao J; Lu Q; Wei JF; Yang H
Cancer Commun (Lond); 2021 Jul; 41(7):560-575. PubMed ID: 33991457
[TBL] [Abstract][Full Text] [Related]
31. HSP40 interacts with pyruvate kinase M2 and regulates glycolysis and cell proliferation in tumor cells.
Huang L; Yu Z; Zhang T; Zhao X; Huang G
PLoS One; 2014; 9(3):e92949. PubMed ID: 24658033
[TBL] [Abstract][Full Text] [Related]
32. Pyruvate kinase M2: A simple molecule with complex functions.
Alquraishi M; Puckett DL; Alani DS; Humidat AS; Frankel VD; Donohoe DR; Whelan J; Bettaieb A
Free Radic Biol Med; 2019 Nov; 143():176-192. PubMed ID: 31401304
[TBL] [Abstract][Full Text] [Related]
33. Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [
Patel CB; Beinat C; Xie Y; Chang E; Gambhir SS
Neoplasia; 2021 Jan; 23(1):58-67. PubMed ID: 33221711
[TBL] [Abstract][Full Text] [Related]
34. Glycolytic reprogramming in cancer cells: PKM2 dimer predominance induced by pulsatile PFK-1 activity.
Shi X; You L; Luo RY
Phys Biol; 2019 Sep; 16(6):066007. PubMed ID: 31469100
[TBL] [Abstract][Full Text] [Related]
35. Dihydroartemisinin represses esophageal cancer glycolysis by down-regulating pyruvate kinase M2.
Li S; Huang P; Gan J; Ling X; Du X; Liao Y; Li L; Meng Y; Li Y; Bai Y
Eur J Pharmacol; 2019 Jul; 854():232-239. PubMed ID: 31004604
[TBL] [Abstract][Full Text] [Related]
36. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.
Yacovan A; Ozeri R; Kehat T; Mirilashvili S; Sherman D; Aizikovich A; Shitrit A; Ben-Zeev E; Schutz N; Bohana-Kashtan O; Konson A; Behar V; Becker OM
Bioorg Med Chem Lett; 2012 Oct; 22(20):6460-8. PubMed ID: 22963766
[TBL] [Abstract][Full Text] [Related]
37. The role of PKM2 in cancer progression and its structural and biological basis.
Wu B; Liang Z; Lan H; Teng X; Wang C
J Physiol Biochem; 2024 May; 80(2):261-275. PubMed ID: 38329688
[TBL] [Abstract][Full Text] [Related]
38. Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway.
Zhu Q; Hong B; Zhang L; Wang J
J Cancer Res Ther; 2018 Sep; 14(Supplement):S616-S621. PubMed ID: 30249877
[TBL] [Abstract][Full Text] [Related]
39. Effect of modified Jianpi Yangzheng on regulating content of PKM2 in gastric cancer cells-derived exosomes.
Wu J; Yuan M; Shen J; Chen Y; Zhang R; Chen X; Wang H; Yin Z; Zhang X; Liu S; Sun Q
Phytomedicine; 2022 Aug; 103():154229. PubMed ID: 35691076
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma.
Dey P; Son JY; Kundu A; Kim KS; Lee Y; Yoon K; Yoon S; Lee BM; Nam KT; Kim HS
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
